PATENT CLAIM ANALYSIS

Application Number: 15937388
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "274100"]

Abstract:
This invention provides novel injectable compositions comprising botulinum toxin that may be administered to a subject for various therapeutic, aesthetic and/or cosmetic purposes. The injectable compositions contemplated by the invention exhibit one or more advantages over conventional botulinum toxin formulations, including reduced antigenicity, a reduced tendency to undergo unwanted localized diffusion following injection, increased duration of clinical efficacy or enhanced potency relative, faster onset of clinical efficacy, and/or improved stability.

Claim (Index 18):
The kit according to  claim 17 , wherein said botulinum toxin component is present in an amount from 30 to 250 U.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 90.0
- Lexical Diversity: 1.32203
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13141935', '14935886', '11367642', '11072026', '11816602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7394697840117085
- 35 USC 102 Novelty (BERT): 0.5694415778837639
- Combined Prediction Score: 0.722466963398914
- Mean Citation Score: 360.877898
- Max Citation Score: 453.47833
- Similarity Product: 359.82497569434884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test